Answers are grounded in this paper and cite their sources.
Alzheimer’s disease is a neurodegenerative disorder affecting millions across the world. It is caused by the progressive build-up of Amyloid-β plaques and tau tangles resulting in inflammation in neurons, followed by apoptosis. This paper aims to synthesize the findings of various researchers on Alzheimer’s Diseases to shed light on a treatment using molecules that promote the survival and proliferation of neurons - neurotrophic factors. Each family of neurotrophic factors has different functions and after evaluating each one, brain-derived neurotrophic factor (BDNF) was shown to have the most potential in treating Alzheimer’s disease. Nano therapy was considered as a carrier for BDNF to cross the blood-brain barrier. PolyPGLA was found to be the most effective nanocarrier for BDNF.
No takes yet. Share an insight, caveat, or question.
Elijah James Kurien (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: